Viropro Inc.
VPRO · OTC
12/31/2010 | 11/30/2009 | 11/30/2008 | 11/30/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.02 | 0.01 | 0.02 |
| FCF Yield | -54.59% | -31.66% | -256.01% | -24.56% |
| EV / EBITDA | -1.40 | -2.84 | -1.95 | -4.25 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 100.00% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 0.67 | 0.49 | 0.50 | 0.27 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -100.00% | – | – |
| Free Cash Flow Growth | 6.92% | 23.22% | -30.14% | 46.79% |
| Safety | ||||
| Net Debt / EBITDA | -0.12 | -0.05 | -1.49 | -0.73 |
| Interest Coverage | -73.09 | -1.38 | -1.46 | -2.15 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 66.41 | 0.00 | 0.00 | 29.56 |